In Pennsylvania, researchers are using genomic profiling to help future treatment of pancreatic cancer, which is the third leading cause of cancer deaths in the United States and has a low survival rate of 8%. One study found a mutation in the anaplastic lymphoma kinase gene and used targeted therapy for the mutated gene. Another study used existing medicines to improve pancreatic cancer outcomes with similar genetic mutations. The key was using the targeted genetic therapy early on as they found patients who had advanced too far with pancreatic cancer did not benefit as much as patients who were in the earlier stages.
Latest article
New yoga fabric collection from Hyosung TNC and Lenzing “nama-stays” away from synthetic fibers
In South Korea, global elastane leader Hyosung TNC and Lenzing Group, a leading global producer of regenerated cellulosic fibers for the textile and nonwovens...
Egg carton kicks explore intersection of design and simplicity
In Prague, Kibardin Design has created a sneaker concept out of recycled egg cartons. Dubbed Egg Box Sneakers, the design project combines art, fashion...
Oyster waste provides pleasant “shell-ter” for Sydney parkgoers
In Sydney, Australia, a new Pier Pavilion designed by Besley & Spresser has been built using waste rock oyster shells.
Comprising a “striking landscape...